{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:04:58Z","timestamp":1791324298030,"version":"4.3.1"},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.6312","type":"journal-article","created":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T18:07:37Z","timestamp":1464718057000},"page":"1439-1445","source":"Crossref","is-referenced-by-count":10,"title":["Clinical Impact of a Humanized CCR4 Antibody (Mogamulizumab) in 14 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated at a Single Institution During a Three-year Period (2012-2014)"],"prefix":"10.2169","volume":"55","author":[{"given":"Noriaki","family":"Kawano","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Kuriyama","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koh-Hei","family":"Sonoda","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Yamaguchi University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuro","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenobu","family":"Ochiai","sequence":"additional","affiliation":[{"name":"Trauma and Critical Care Center, Faculty of Medicine, University of Miyazaki Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Shimoda","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hematology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Research Unit for Human Disease Models, RIKEN Research Center for Allergy and Immunology, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuo","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","volume":"50","author":"T Uchiyama","year":"1977","unstructured":"1. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 50: 481-492, 1977.","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Yoshida M, Seiki M, Yamaguchi K, Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci USA 81: 2534-2537, 1984.","DOI":"10.1073\/pnas.81.8.2534"},{"key":"3","unstructured":"3. Tajima K, Kuroishi T. Estimation of rate of incidence of ATL among ATLV (HTLV-I) carriers in Kyushu, Japan. Jpn J Clin Oncol 15: 423-430, 1985."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemialymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol 79: 428-437, 1991.","DOI":"10.1111\/j.1365-2141.1991.tb08051.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Yamada Y, Tomonaga M, Fukuda H, et al. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol 113: 375-382, 2001.","DOI":"10.1046\/j.1365-2141.2001.02737.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Tsukasaki K, Utsunomiya A, Fukuda H, et al. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol 25: 5458-5464, 2007.","DOI":"10.1200\/JCO.2007.11.9958"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Tsukasaki K, Hermine O, Bazarbachi A, et al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol 27: 453-459, 2009.","DOI":"10.1200\/JCO.2008.18.2428"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ishitsuka K, Tamura K. Treatment of adult T-cell leukemia\/lymphoma: past, present, and future. Eur J Haematol 80: 185-196, 2008.","DOI":"10.1111\/j.1600-0609.2007.01016.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Uozumi K. Treatment of adult T-cell leukemia. J Clin Exp Hematop 50: 9-25, 2010.","DOI":"10.3960\/jslrt.50.9"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Tsukasaki K, Tobinai K. Clinical Trials and Treatment of ATL. Leuk Res Treatment 2012: 101754, 2012.","DOI":"10.1155\/2012\/101754"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Fukushima T, Miyazaki Y, Honda S, et al. Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia\/lymphoma. Leukemia 19: 829-834, 2005.","DOI":"10.1038\/sj.leu.2403682"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Okamura J, Utsunomiya A, Tanosaki R, et al. Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia\/lymphoma. Blood 105: 4143-4145, 2005.","DOI":"10.1182\/blood-2004-11-4193"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Tanosaki R, Uike N, Utsunomiya A, et al. Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning for adult T cell leukemia\/lymphoma: impact of antithymocyte globulin on clinical outcome. Biol Blood Marrow Transplant 14: 702-708, 2008.","DOI":"10.1016\/j.bbmt.2008.03.010"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Hishizawa M, Kanda J, Utsunomiya A, et al. Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study. Blood 116: 1369-1376, 2010.","DOI":"10.1182\/blood-2009-10-247510"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Ishida T, Hishizawa M, Kato K, et al. Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study. Blood 120: 1734-1741, 2012.","DOI":"10.1182\/blood-2012-03-414490"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Yamada Y, Atogami S, Hasegawa H, et al. Nationwide survey of adult T-cell leukemia\/lymphoma (ATL) in Japan. Rinsho Ketsueki 52: 1765-1771, 2011.","DOI":"10.11406\/rinketsu.52.1765"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kawano N, Yoshida S, Kuriyama T, et al. Clinical Features and Treatment Outcomes of 81 Patients with Aggressive Type Adult T-cell Leukemia-Lymphoma at a Single Institution over a 7-year Period (2006-2012). Intern med 54: 1489-1498, 2015.","DOI":"10.2169\/internalmedicine.54.1953"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ishida T, Joh T, Uike N, et al. Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. J Clin Oncol 30: 837-842, 2012.","DOI":"10.1200\/JCO.2011.37.3472"},{"key":"19","unstructured":"19. Taniguchi H, Imaizumi Y, Makiyama J, et al. Outcome of patients with relapsed\/refractory adult T-cell leukemia-lymphoma after salvage therapy. Rinsho Ketsueki (Jpn J Clin Hematol) 54: 2159-2166, 2013 (in Japanese, Abstract in English)."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Jo T, Ishida T, Takemoto S, et al. Randomoized phase II study of mogamulizumab (KW-0761) plus mLSG 15 versus mLSG 15 alone for newly diagnosed aggressive ATL. J Clin Oncol 31: 8506, 2013.","DOI":"10.1200\/jco.2013.31.15_suppl.8506"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ishida T, Ito A, Sato F, et al. Stevens-Johnson Syndrome associated with mogamulizumab treatment of adult T-cell leukemia\/lymphoma. Cancer Sci 104: 647-650, 2013.","DOI":"10.1111\/cas.12116"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Yonekura K, Kanzaki T, Gunshin K, et al. Effect of anti-CCR4 monoclonal antibody (mogamulizumab) on adult T-cell leukemia-lymphoma: cutaneous adverse reactions may predict the prognosis. J Dermatol 41: 239-244, 2014.","DOI":"10.1111\/1346-8138.12419"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/11\/55_55.6312\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T07:06:35Z","timestamp":1600671995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/11\/55_55.6312\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.6312","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726483888.793556720","asserted-by":"object"}]},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}